ArticleRespiratory research2022

Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.

Linlin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.